The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

R Cremers; RA Eeles; EK Bancroft; J Ringelberg; HF Vasen; CJ van Asperen; JA Schalken; GW Verhaegh; LA Kiemeney; N Aaronson; A Ardem-Jones; C.H. Bangma; E Castro; D Dearnaley; D Eccles; DGR Evans; J Eyfjord; A Falconer; CS (Christopher) Foster; H Gronberg; FC Hamdy; O Johansson; V Khoo; Z Kote-Jarai; H Lija; J Lubinski; L Maehle; J Melia; C Mikropoulos; G Mitchell; AV Mitra; S Moss; C Moynihan; EC Page; G Rennert; M Suri; P Wilson

doi:10.1016/j.urolonc.2015.01.018

The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

R Cremers
, RA Eeles
, EK Bancroft
, J Ringelberg
, HF Vasen
, CJ van Asperen
, JA Schalken
, GW Verhaegh
, LA Kiemeney
, N Aaronson
, A Ardem-Jones
, C.H. Bangma
, E Castro
, D Dearnaley
, D Eccles
, DGR Evans
, J Eyfjord
, A Falconer
, CS (Christopher) Foster
, H Gronberg

FC Hamdy, O Johansson, V Khoo, Z Kote-Jarai, H Lija, J Lubinski, L Maehle, J Melia, C Mikropoulos, G Mitchell, AV Mitra, S Moss, C Moynihan, EC Page, G Rennert, M Suri, P Wilson

Urology

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

35 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	202e19-202e28
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	33
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2015.01.018
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-49-01

Access to Document

10.1016/j.urolonc.2015.01.018

REPUB_91744-OA.pdfFinal published version, 815 KB

Cite this

Cremers, R., Eeles, RA., Bancroft, EK., Ringelberg, J., Vasen, HF., van Asperen, CJ., Schalken, JA., Verhaegh, GW., Kiemeney, LA., Aaronson, N., Ardem-Jones, A., Bangma, C. H., Castro, E., Dearnaley, D., Eccles, D., Evans, DGR., Eyfjord, J., Falconer, A., Foster, CS., ... Wilson, P. (2015). The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers. Urologic Oncology: Seminars and Original Investigations, 33(5), 202e19-202e28. https://doi.org/10.1016/j.urolonc.2015.01.018

@article{8984945bd845433c88515b835b2a9dc0,

title = "The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers",

author = "R Cremers and RA Eeles and EK Bancroft and J Ringelberg and HF Vasen and \{van Asperen\}, CJ and JA Schalken and GW Verhaegh and LA Kiemeney and N Aaronson and A Ardem-Jones and C.H. Bangma and E Castro and D Dearnaley and D Eccles and DGR Evans and J Eyfjord and A Falconer and Foster, \{CS (Christopher)\} and H Gronberg and FC Hamdy and O Johansson and V Khoo and Z Kote-Jarai and H Lija and J Lubinski and L Maehle and J Melia and C Mikropoulos and G Mitchell and AV Mitra and S Moss and C Moynihan and EC Page and G Rennert and M Suri and P Wilson",

year = "2015",

doi = "10.1016/j.urolonc.2015.01.018",

language = "Undefined/Unknown",

volume = "33",

pages = "202e19--202e28",

number = "5",

}

Cremers, R, Eeles, RA, Bancroft, EK, Ringelberg, J, Vasen, HF, van Asperen, CJ, Schalken, JA, Verhaegh, GW, Kiemeney, LA, Aaronson, N, Ardem-Jones, A, Bangma, CH, Castro, E, Dearnaley, D, Eccles, D, Evans, DGR, Eyfjord, J, Falconer, A, Foster, CS, Gronberg, H, Hamdy, FC, Johansson, O, Khoo, V, Kote-Jarai, Z, Lija, H, Lubinski, J, Maehle, L, Melia, J, Mikropoulos, C, Mitchell, G, Mitra, AV, Moss, S, Moynihan, C, Page, EC, Rennert, G, Suri, M & Wilson, P 2015, 'The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers', Urologic Oncology: Seminars and Original Investigations, vol. 33, no. 5, pp. 202e19-202e28. https://doi.org/10.1016/j.urolonc.2015.01.018

The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers. / Cremers, R; Eeles, RA; Bancroft, EK et al.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 33, No. 5, 2015, p. 202e19-202e28.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

AU - Cremers, R

AU - Eeles, RA

AU - Bancroft, EK

AU - Ringelberg, J

AU - Vasen, HF

AU - van Asperen, CJ

AU - Schalken, JA

AU - Verhaegh, GW

AU - Kiemeney, LA

AU - Aaronson, N

AU - Ardem-Jones, A

AU - Bangma, C.H.

AU - Castro, E

AU - Dearnaley, D

AU - Eccles, D

AU - Evans, DGR

AU - Eyfjord, J

AU - Falconer, A

AU - Foster, CS (Christopher)

AU - Gronberg, H

AU - Hamdy, FC

AU - Johansson, O

AU - Khoo, V

AU - Kote-Jarai, Z

AU - Lija, H

AU - Lubinski, J

AU - Maehle, L

AU - Melia, J

AU - Mikropoulos, C

AU - Mitchell, G

AU - Mitra, AV

AU - Moss, S

AU - Moynihan, C

AU - Page, EC

AU - Rennert, G

AU - Suri, M

AU - Wilson, P

PY - 2015

Y1 - 2015

U2 - 10.1016/j.urolonc.2015.01.018

DO - 10.1016/j.urolonc.2015.01.018

M3 - Article

C2 - 25746941

SN - 1078-1439

VL - 33

SP - 202e19-202e28

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -

Cremers R, Eeles RA, Bancroft EK, Ringelberg J, Vasen HF, van Asperen CJ et al. The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers. Urologic Oncology: Seminars and Original Investigations. 2015;33(5):202e19-202e28. doi: 10.1016/j.urolonc.2015.01.018